238 related articles for article (PubMed ID: 19041304)
1. Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.
Levine S; Saltzman A; Levy E; Ginsberg SD
Exp Mol Pathol; 2009 Feb; 86(1):18-22. PubMed ID: 19041304
[TBL] [Abstract][Full Text] [Related]
2. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
[TBL] [Abstract][Full Text] [Related]
3. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
[TBL] [Abstract][Full Text] [Related]
4. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
5. Temporal and brain region-specific elevations of soluble Amyloid-β
Tallino S; Winslow W; Bartholomew SK; Velazquez R
Aging Cell; 2022 Apr; 21(4):e13590. PubMed ID: 35290711
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
[TBL] [Abstract][Full Text] [Related]
7. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
8. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
Kumar S; Lemere CA; Walter J
Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
[TBL] [Abstract][Full Text] [Related]
10. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.
Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB
Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
[TBL] [Abstract][Full Text] [Related]
13. Molecular neuropathology of transgenic mouse models of Down syndrome.
Cairns NJ
J Neural Transm Suppl; 2001; (61):289-301. PubMed ID: 11771752
[TBL] [Abstract][Full Text] [Related]
14. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
[TBL] [Abstract][Full Text] [Related]
15. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.
Jiang Y; Rigoglioso A; Peterhoff CM; Pawlik M; Sato Y; Bleiwas C; Stavrides P; Smiley JF; Ginsberg SD; Mathews PM; Levy E; Nixon RA
Neurobiol Aging; 2016 Mar; 39():90-8. PubMed ID: 26923405
[TBL] [Abstract][Full Text] [Related]
16. Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.
Wiseman FK; Pulford LJ; Barkus C; Liao F; Portelius E; Webb R; Chávez-Gutiérrez L; Cleverley K; Noy S; Sheppard O; Collins T; Powell C; Sarell CJ; Rickman M; Choong X; Tosh JL; Siganporia C; Whittaker HT; Stewart F; Szaruga M; ; Murphy MP; Blennow K; de Strooper B; Zetterberg H; Bannerman D; Holtzman DM; Tybulewicz VLJ; Fisher EMC;
Brain; 2018 Aug; 141(8):2457-2474. PubMed ID: 29945247
[TBL] [Abstract][Full Text] [Related]
17. Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
Head E; Lott IT; Wilcock DM; Lemere CA
Curr Alzheimer Res; 2016; 13(1):18-29. PubMed ID: 26651341
[TBL] [Abstract][Full Text] [Related]
18. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
Doran E; Keator D; Head E; Phelan MJ; Kim R; Totoiu M; Barrio JR; Small GW; Potkin SG; Lott IT
J Alzheimers Dis; 2017; 56(2):459-470. PubMed ID: 27983553
[TBL] [Abstract][Full Text] [Related]
19. The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
Wu Y; Whittaker HT; Noy S; Cleverley K; Brault V; Herault Y; Fisher EMC; Wiseman FK
PLoS One; 2021; 16(7):e0242236. PubMed ID: 34292972
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model.
Choi JH; Berger JD; Mazzella MJ; Morales-Corraliza J; Cataldo AM; Nixon RA; Ginsberg SD; Levy E; Mathews PM
J Neurochem; 2009 Sep; 110(6):1818-27. PubMed ID: 19619138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
